BCL9L and neoplasm: Consistently, positive regulation of T cell proliferation in cDC1 was also upregulated in tumors of B16-OVA tumor-bearing Bcl9/Bcl9l deficiency mice, supporting that cDC1 primed CD8+ T cells (Fig. 4f and Supplementary Fig. 8b).